共有 50 笔近期内部人交易记录记录，涉及 CVRx, Inc. (CVRX), 包括 30 笔买入 和 14 笔卖出. 内部人买入总额为 $7.54M 内部人卖出总额为 $1.01M.
近期活跃的重要内部人包括 Hykes Kevin, Oasheim Jared, Verrastro Paul. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CVRX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-02 |
Hykes Kevin |
Pres & CEO |
知情卖出 |
7,763 |
$7.90 |
$61.35K |
284,237 |
| 2026-03-02 |
Oasheim Jared |
Chief Financial Officer |
知情卖出 |
1,744 |
$7.90 |
$13.78K |
96,703 |
| 2026-03-02 |
Verrastro Paul |
Chief Mktg & Strat Officer |
知情卖出 |
1,284 |
$7.90 |
$10.15K |
60,551 |
| 2026-03-02 |
John Robert Allen |
Chief Revenue Officer |
知情卖出 |
3,964 |
$7.90 |
$31.33K |
86,036 |
| 2026-03-02 |
Morrison Gregory |
Officer |
未知 |
- |
- |
- |
- |
| 2026-03-02 |
Morrison Gregory |
Chief Human Resources Officer |
限制性股票授予 (RSU) |
34,000 |
- |
- |
34,000 |
| 2026-03-02 |
Adamson Philip B. |
Chief Medical Officer |
知情卖出 |
1,262 |
$7.90 |
$9.97K |
61,578 |
| 2026-02-27 |
Hykes Kevin |
Pres & CEO |
限制性股票授予 (RSU) |
238,000 |
$8.16 |
$1.94M |
238,000 |
| 2026-02-27 |
Binkowski Brent |
Chief Operating Officer |
限制性股票授予 (RSU) |
23,000 |
$8.16 |
$187.68K |
23,000 |
| 2026-02-27 |
Oasheim Jared |
Chief Financial Officer |
限制性股票授予 (RSU) |
91,000 |
$8.16 |
$742.56K |
91,000 |
| 2026-02-27 |
Verrastro Paul |
Chief Mktg & Strat Officer |
限制性股票授予 (RSU) |
45,000 |
- |
- |
61,835 |
| 2026-02-27 |
John Robert Allen |
Chief Revenue Officer |
限制性股票授予 (RSU) |
52,000 |
$8.16 |
$424.32K |
52,000 |
| 2026-02-27 |
Adamson Philip B. |
Chief Medical Officer |
限制性股票授予 (RSU) |
62,000 |
$8.16 |
$505.92K |
62,000 |
| 2026-02-20 |
Jain Mudit K. |
Director |
知情买入 |
46,800 |
$6.36 |
$297.59K |
980,183 |
| 2026-02-18 |
Jain Mudit K. |
Director |
知情买入 |
600 |
$4.64 |
$2.79K |
5,650 |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
6,337 |
$10.03 |
$63.56K |
4,024,861 |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
6,337 |
$10.03 |
$63.56K |
4,040,861 |
| 2025-11-25 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
16,000 |
$10.03 |
$160.48K |
4,031,198 |
| 2025-11-24 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
2,200 |
$10.06 |
$22.13K |
4,047,198 |
| 2025-11-21 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
500 |
$10.00 |
$5K |
4,049,398 |
| 2025-11-12 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
1,000 |
$10.00 |
$10K |
4,049,898 |
| 2025-11-07 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
200 |
$10.00 |
$2K |
4,050,898 |
| 2025-11-06 |
Johnson & Johnson |
10 Percent Owner |
知情卖出 |
52,332 |
$10.21 |
$534.31K |
4,051,098 |
| 2025-08-11 |
Binkowski Brent |
Officer |
未知 |
- |
- |
- |
- |
| 2025-08-11 |
Binkowski Brent |
Chief Operating Officer |
限制性股票授予 (RSU) |
16,600 |
- |
- |
16,600 |
| 2025-06-03 |
Slattery Joseph P |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Nielsen Kirk G. |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Ballinger Kevin J. |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Jain Mudit K. |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Hill, Mitch C. |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Shadan Martha |
Director |
限制性股票授予 (RSU) |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-05-15 |
Nielsen Kirk G. |
Director |
知情买入 |
10,966 |
$5.45 |
$59.8K |
1,910,134 |
| 2025-05-14 |
Nielsen Kirk G. |
Director |
知情买入 |
61,200 |
$5.23 |
$320.36K |
1,899,168 |
| 2025-05-13 |
Jain Mudit K. |
Director |
知情买入 |
150 |
$5.26 |
$789.00 |
5,050 |
| 2025-05-13 |
Nielsen Kirk G. |
Director |
知情买入 |
101,413 |
$5.29 |
$536.31K |
1,837,968 |
| 2025-05-12 |
Hykes Kevin |
Pres & CEO |
知情买入 |
5,000 |
$4.84 |
$24.2K |
133,000 |
| 2025-05-12 |
Jain Mudit K. |
Director |
知情买入 |
1,500 |
$4.66 |
$6.99K |
4,900 |
| 2025-05-12 |
Nielsen Kirk G. |
Director |
知情买入 |
25,200 |
$4.79 |
$120.67K |
1,736,555 |
| 2025-02-28 |
Hykes Kevin |
Pres & CEO |
限制性股票授予 (RSU) |
98,000 |
- |
- |
128,000 |
| 2025-02-28 |
Oasheim Jared |
Chief Financial Officer |
限制性股票授予 (RSU) |
33,000 |
$12.96 |
$427.68K |
33,000 |
| 2025-02-28 |
Verrastro Paul |
Chief Mktg & Strat Officer |
限制性股票授予 (RSU) |
16,000 |
- |
- |
16,835 |
| 2025-02-28 |
John Robert Allen |
Chief Revenue Officer |
限制性股票授予 (RSU) |
38,000 |
$12.96 |
$492.48K |
38,000 |
| 2025-02-28 |
Adamson Philip B. |
Chief Medical Officer |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2025-02-04 |
Adamson Philip B. |
Chief Medical Officer |
未知 |
190,208 |
$7.82 |
$1.49M |
- |
| 2024-11-21 |
Verrastro Paul |
Chief Mktg & Strat Officer |
赠与（送出） |
1,040 |
- |
- |
835 |
| 2024-11-19 |
Verrastro Paul |
Chief Mktg & Strat Officer |
知情卖出 |
1,430 |
$13.58 |
$19.42K |
1,875 |
| 2024-09-03 |
Ballinger Kevin J. |
Officer |
未知 |
- |
- |
- |
- |
| 2024-09-03 |
Ballinger Kevin J. |
Director |
限制性股票授予 (RSU) |
36,136 |
$9.05 |
$327.03K |
36,136 |
| 2024-09-03 |
Hill, Mitch C. |
Officer |
未知 |
- |
- |
- |
- |
| 2024-09-03 |
Hill, Mitch C. |
Director |
限制性股票授予 (RSU) |
36,136 |
$9.05 |
$327.03K |
36,136 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
